Loading...
OTCM
ERGO
Market cap3kUSD
Jul 08, Last price  
0.00USD
1D
0.00%
Jan 2017
-99.82%
IPO
-99.89%
Name

Entia Biosciences Inc

Chart & Performance

D1W1MN
P/E
P/S
0.01
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
265k
-23.48%
0067,608382,051403,338369,273314,746656,342346,910265,466
Net income
-1m
L-38.88%
-400-121,135-694,454-1,266,315-1,729,103-1,527,077-3,249,516-2,636,300-2,409,334-1,472,664
CFO
-715k
L+33.27%
-400-304,783-689,658-522,930-208,744-314,595-766,733-680,284-536,565-715,098

Profile

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
IPO date
Nov 01, 2007
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFY
2016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT